Welcome to the dedicated Spotlight On Policy page, your central resource for curated, expert-driven coverage of pharmaceutical and health system policy across the United States, the United Kingdom, Europe, and the wider global landscape. US Policy updates News New York declares measles outbreak a "disaster emergency" The governor of New York has said rising cases of measles constitute a statewide disaster emergency, as cases in neighbouring Pennsylvania pass 1,000. News GLOBE model finalised, with narrowed scope and fewer savings CMS has finalised a new drug pricing policy for Medicare that has drawn sharp criticism from the pharma industry. News PhRMA hires ex-House Majority Leader Eric Cantor as its CEO Former Republican lawmaker Eric Cantor has been named as the new CEO of US pharma group PhRMA, replacing long-serving Stephen Ubl. Market Access What the revised 340B rebate pilot programme means for pharm... While the scope of the revised pilot is limited, it may be a harbinger for a broader policy shift. more EU Policy updates Market Access Beyond Market Access: Why healthcare-system understanding is... Healthcare-system literacy, and the ability to contribute to system shaping, must become part of how healthcare leaders make decisions. News Pharma leaders urge Europe to halt 'slow agony' of decline Europe's top pharma firms have called on governments to take action to change the region's story from one of decay to one of "renewal and resilience." Market Access Sponsored Europe for life sciences and for patients, with BeOne Medici... In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Giancarlo Benelli, SVP & Head of Europe at BeOne Medicines. Market Access The EU Joint Clinical Assessment in practice: Early lessons Unfortunately, much of the discussion around the JCA has focused on how the framework is intended to operate, rather than how it works in practice. more UK Policy updates News UK puts £80m behind dementia diagnosis push The UK is putting £80 million ($105 million) in funding behind nine technologies that it hopes will be able to diagnose dementia more quickly. Market Access Request to look further into NICE non-submissions in the fut... Leela Barham looks at the discussion on non-submissions to the HTA body NICE, informed by the latest metrics for VPAG. News MHRA clarifies UK position on microbiome-based medicines The MHRA has published its position paper clarifying how microbiome-based medicines can be made available for patients in the UK. Patients Innovation can transform NHS care, but scaling is the missin... Innovation is already improving care across the NHS, but we are not yet consistently delivering at scale for the benefit of patients more
News New York declares measles outbreak a "disaster emergency" The governor of New York has said rising cases of measles constitute a statewide disaster emergency, as cases in neighbouring Pennsylvania pass 1,000.
News GLOBE model finalised, with narrowed scope and fewer savings CMS has finalised a new drug pricing policy for Medicare that has drawn sharp criticism from the pharma industry.
News PhRMA hires ex-House Majority Leader Eric Cantor as its CEO Former Republican lawmaker Eric Cantor has been named as the new CEO of US pharma group PhRMA, replacing long-serving Stephen Ubl.
Market Access What the revised 340B rebate pilot programme means for pharm... While the scope of the revised pilot is limited, it may be a harbinger for a broader policy shift.
Market Access Beyond Market Access: Why healthcare-system understanding is... Healthcare-system literacy, and the ability to contribute to system shaping, must become part of how healthcare leaders make decisions.
News Pharma leaders urge Europe to halt 'slow agony' of decline Europe's top pharma firms have called on governments to take action to change the region's story from one of decay to one of "renewal and resilience."
Market Access Sponsored Europe for life sciences and for patients, with BeOne Medici... In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Giancarlo Benelli, SVP & Head of Europe at BeOne Medicines.
Market Access The EU Joint Clinical Assessment in practice: Early lessons Unfortunately, much of the discussion around the JCA has focused on how the framework is intended to operate, rather than how it works in practice.
News UK puts £80m behind dementia diagnosis push The UK is putting £80 million ($105 million) in funding behind nine technologies that it hopes will be able to diagnose dementia more quickly.
Market Access Request to look further into NICE non-submissions in the fut... Leela Barham looks at the discussion on non-submissions to the HTA body NICE, informed by the latest metrics for VPAG.
News MHRA clarifies UK position on microbiome-based medicines The MHRA has published its position paper clarifying how microbiome-based medicines can be made available for patients in the UK.
Patients Innovation can transform NHS care, but scaling is the missin... Innovation is already improving care across the NHS, but we are not yet consistently delivering at scale for the benefit of patients
